Urge your members of Congress to support continued medical research funding
Today, the American Society of Hematology submitted feedback on draft recommendations for reforming Maintenance of Certification (MOC) to a commission appointed by the American Board of Medical Specialties (ABMS) and other entities.
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood.
The editors of Blood, the most-cited journal in hematology, have selected the top manuscripts of 2018.
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.
Today, Congress passed the bi-partisan Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018.
Three studies being presented today during the 60th ASH Annual Meeting and Exposition in San Diego offer more targeted solutions for managing CLL and multiple myeloma.
Four late-breaking studies being presented today during the 60th ASH Annual Meeting and Exposition in San Diego offer groundbreaking solutions to challenges in diagnosing and managing bleeding and clotting and genetic blood disorders.
ASH will recognize three Choosing Wisely® Champions, practitioners working to tackle overuse of hematology tests and treatments, today at its 60th annual meeting in San Diego.
Today during the 60th American Society of Hematology Annual Meeting and Exposition in San Diego, presenters of three studies will highlight how recent technological developments are translating into clinically relevant advances for hard-to-treat blood disorders.
Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types of aggressive blood cancers, in whom treatment options have been woefully limited.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology